Liver-directed AAV-IL-10 therapy enhances CD8+ T cell-mediated immunity against hepatocellular carcinoma. - Lin CI; Chiu YW; Yen MS; Wang YW; Wu YH; Chuang YH (Journal for immunotherapy of cancer, 2026)